lucitanib,nivolumab,ramucirumab,e 3810
clovis oncology,servier,bms,eli lilly
['nivo', 'gynca', 'lucitanib', '4042', 'nivolumab', 'lio-1', 'engot-gyn3', 'gyn']
dr. fernanda musa participates on the engot trial for #gyncancer presented at #asco22: efficacy and safety of lucitanib + nivolumab in patients with advanced gynecologic malignancies: phase 2 results from the lio-1 study (nct04042116; engot-gyn3/ago/lio). 
Sharing #Cancer #Research news updates from @Swedish Cancer Institute. Personalized medicine. Leading research.

Tweets do not constitute medical advice